Evidence map›Paper›PMID 41148446›Full record

ArticleDiscover oncology2025

A rare case of primary transverse colon adenocarcinoma penetrating the abdominal wall.

Boren Tan, Lei Liu, Huiming Wu, Qi Bao, Xiaoming Xu, Hongfeng Cao, Liuhong Wang, Yeting Hu, Jingjing Wu, Jian Wang

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Boren Tan *Department of Colorectal Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, Key Laboratory of Molecular Biology in Medical Sciences, Cancer Institute, National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
Lei Liu *Department of Colorectal Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, Key Laboratory of Molecular Biology in Medical Sciences, Cancer Institute, National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
Huiming WuDepartment of Colorectal Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, Key Laboratory of Molecular Biology in Medical Sciences, Cancer Institute, National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
Qi BaoDepartment of Plastic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Xiaoming XuDepartment of Pathology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Hongfeng CaoDepartment of Colorectal Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, Key Laboratory of Molecular Biology in Medical Sciences, Cancer Institute, National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
Liuhong WangDepartment of Radiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Yeting HuDepartment of Colorectal Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, Key Laboratory of Molecular Biology in Medical Sciences, Cancer Institute, National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
Jingjing WuDepartment of Colorectal Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, Key Laboratory of Molecular Biology in Medical Sciences, Cancer Institute, National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China. wujingjing@zju.edu.cn.
Jian WangDepartment of Colorectal Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, Key Laboratory of Molecular Biology in Medical Sciences, Cancer Institute, National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China. wangjian519@zju.edu.cn.

Funding

National Natural Science Foundation of China 82072621National Natural Science Foundation of China 82372790
6 · The paper itself

Abstract

Colorectal cancer (CRC) is the third most prevalent malignancy globally and the second leading cause of cancer mortality as of 2020. Its clinical presentation varies by stage, progressing from asymptomatic early disease to advanced symptoms (e.g., rectal bleeding, bowel habit alterations), while unusual manifestations may signal locally advanced disease. Locally advanced CRC is rare, without metastasis representing a critical therapeutic window for curative surgery or neoadjuvant therapy. However, primary locally advanced CRC penetrating the abdominal wall from the intra-abdominal cavity remain unreported. In this report, we describe a rare case of a 78-year-old male who had primary invasive transverse colon adenocarcinoma penetrating the abdominal wall, forming an externally visible mass measuring approximately 9 × 5 cm without lymph node or distinct metastasis. After the pathologically diagnosis of colon adenocarcinoma, the patient received a radical resection surgery combined with abdominal wall reconstruction using a skin flap, followed by six months of capecitabine-based adjuvant chemotherapy. The patient showed no relapse or progression during the one year follow-up after the operation. This rare case highlights the ongoing challenges in managing locally advanced CRC and underscores the potential benefits of active curative treatment strategies for such patients.

Indexed as

AdenocarcinomaColorectalPenetrationPrimary tumorRadical resection surgery

Identifiers

PMID41148446
PMCPMC12569304

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.